1. Home
  2. EBON vs NOTV Comparison

EBON vs NOTV Comparison

Compare EBON & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

N/A

Current Price

$2.34

Market Cap

19.5M

Sector

Technology

ML Signal

N/A

Logo Inotiv Inc.

NOTV

Inotiv Inc.

N/A

Current Price

$0.45

Market Cap

12.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBON
NOTV
Founded
2010
1974
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
12.7M
IPO Year
2020
1997

Fundamental Metrics

Financial Performance
Metric
EBON
NOTV
Price
$2.34
$0.45
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
4.0K
553.8K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
49.64
EPS
N/A
N/A
Revenue
N/A
$547,656,000.00
Revenue This Year
N/A
$5.28
Revenue Next Year
N/A
$5.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
511.19
52 Week Low
$2.30
$0.25
52 Week High
$5.90
$3.35

Technical Indicators

Market Signals
Indicator
EBON
NOTV
Relative Strength Index (RSI) 35.21 61.47
Support Level $2.30 $0.26
Resistance Level $3.76 $0.65
Average True Range (ATR) 0.18 0.04
MACD 0.01 0.03
Stochastic Oscillator 5.56 94.82

Price Performance

Historical Comparison
EBON
NOTV

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: